Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (211-220 of 293) with videos related to

Pageof 30
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
British Journal of Haematology|April 11, 2016
Central nervous system involvement in AIDS-related lymphomasStefan K Barta, Jitesh Joshi, Nicolas Mounier, et al.
Seminars in Oncology|February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trialsDavid S Alberts, Franco M Muggia, James Carmichael, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.
Haematologica|August 24, 2014
A new prognostic score for AIDS-related lymphomas in the rituximab-eraStefan K Barta, Xiaonan Xue, Dan Wang, et al.
Journal of the National Cancer Institute|June 5, 2014
Tumor microenvironment of metastasis and risk of distant metastasis of breast cancerThomas E Rohan, Xiaonan Xue, Hung-Mo Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine TherapyWilliam J Gradishar, Denise A Yardley, Rachel Layman, et al.
The Lancet. Oncology|March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation studyGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Pageof 30

Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
British Journal of Haematology|April 11, 2016
Central nervous system involvement in AIDS-related lymphomasStefan K Barta, Jitesh Joshi, Nicolas Mounier, et al.
Seminars in Oncology|February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trialsDavid S Alberts, Franco M Muggia, James Carmichael, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.
Haematologica|August 24, 2014
A new prognostic score for AIDS-related lymphomas in the rituximab-eraStefan K Barta, Xiaonan Xue, Dan Wang, et al.
Journal of the National Cancer Institute|June 5, 2014
Tumor microenvironment of metastasis and risk of distant metastasis of breast cancerThomas E Rohan, Xiaonan Xue, Hung-Mo Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine TherapyWilliam J Gradishar, Denise A Yardley, Rachel Layman, et al.
The Lancet. Oncology|March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation studyGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Pageof 30